AN2 Therapeutics Principal Accounting Officer Sarah Joanne Williams sold 272 shares at $5.53 per share on September 1, 2026. For investors, the disclosed post-sale holding is 66,311 shares, while the transaction price was $5.53 per share in AN2 Therapeutics stock.

Key Highlights

  • Sarah Joanne Williams serves as AN2 Therapeutics’ principal accounting officer.
  • Williams owned 66,311 AN2 Therapeutics shares after the transaction.
  • Sarah Joanne Williams sold 272 AN2 Therapeutics shares at $5.53 per share.

AN2 Therapeutics, Inc. (NASDAQ: ANTX) recorded a 272-share sale by Sarah Joanne Williams at $5.53 per share. The filing identifies Williams as the company’s principal accounting officer.

Williams Retains 66,311 Shares

Williams is AN2 Therapeutics’ principal accounting officer. The transaction took place on September 1, 2026. Following the sale, Williams’ reported ownership stood at 66,311 shares.